Navigation Links
Novel methods for improved breast cancer survival
Date:2/22/2011

This, together with other research within the Breast Cancer Initiative, as the project is called, has been awarded SEK 25 million from the Swedish innovation agency Vinnova. The project is part of the interdisciplinary cancer centre Create Health, where immunologists, tumour biologists, nanotechnologists, bioinformaticians and cancer researchers work together.

"This campaign means that our research can benefit patients earlier", comments Carl Borrebaeck, Professor of Immunotechnology at Lund University and programme director for Create Health.

He and his colleagues aim to significantly shorten the waiting times for test results and information about continued treatment. The idea is to build a diagnostic clinic next to the operating theatre. The tumour can then be analysed while the patient is still on the operating table and the surgeon, oncologist and pathologist can together make a diagnosis and decide on the right treatment.

The research is based on a unique technique developed by the researchers in Lund. By analysing patterns of biomarkers, or protein molecules, in the blood, it is possible to obtain information about what type of cancer the patient has and what the prognosis is.

"We also map the tumour cells' genome. Using this map, we can find out how responses to different types of treatment may relate to specific genes. This knowledge could be of great help in selecting the right treatment", says Carl Borrebaeck.

The Create Health group is also in the process of developing a breast cancer index. Blood and tissue samples from patients with breast tumours are analysed on both protein and gene level and a unique 'fingerprint' of each tumour is obtained.

"Our aim is to analyse all the tumours in southern Sweden. This collection of samples also improves the collaboration between clinicians and researchers, as well as the chances to be able to quickly implement our research results in a clinical setting", emphasises Carsten Rose, Professor of Oncology and head of division at Skne University Hospital.

When it comes to the work on early identification of which patients are at risk of metastasis, the research has come a long way and has now entered its final stage.

"Currently, all women receive the same harsh treatment. However, with our technique it is possible to select which patients actually need it, and therefore also which only need a significantly milder treatment. The improved prognosis can reduce side-effects and unnecessary suffering for the patient, as well as saving a lot of money", says Carsten Rose.

The Breast Cancer Initiative is part of Create Health, which comprises projects run by professors ke Borg (oncology), Peter James (proteomics), Carl Borrebaeck (cancer immunology) and Carsten Rose (oncology).


'/>"/>

Contact: Carl Borrebaeck
Carl.Borrebaeck@rektor.lu.se
46-708-218-330
Lund University
Source:Eurekalert

Related medicine news :

1. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
2. A novel in vitro model for light-induced wound healing
3. Novel program translates behavioral and social science research into treatments to reduce obesity
4. Reovirus may be a novel approach to prostate cancer treatment
5. Novel stroke treatment passes safety stage of UCI-led clinical trial
6. Novel medical home program for pediatric patients, families cuts ER visits in half
7. MessageSolution First in the Market to Offer All-in-One, Integrated Cloud-Based Archiving for Email, File Systems and SharePoint at Novell BrainShare 2010
8. Novel Parkinson's Treatment Strategy Involves Cell Transplantation
9. Novel Method Eyed for Normalizing Blood Sugar
10. Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women
11. Novel nanoparticles prevent radiation damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... Japanese Zen ... Yoga Mat Revolution” on 6th, 7th and 8th October at Miranda Kuo Gallery on ... mat art pieces, such as Zen Kodo mat. Wanderlust , one of the ...
(Date:9/21/2017)... Boulder, CO (PRWEB) , ... September 21, 2017 ... ... Education Interview of the Month, Lewis and Clark College Emeritus Professor of Education ... Associate Faith Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... voice for people who have kidney disease. The theme “Describe a positive decision ... stories. Entrants needed to meet only one qualification— to have been diagnosed ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced ... Aligner clinical and commercial support services market) has entered into an agreement on ... Australia. , The PGSD is the first private Dental School to launch ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey Pot ... Vaginas.” The goal is to ignite conversation via social media and word-of-mouth regarding ... brand has declared September “Humans with Vaginas” month, releasing a video celebrating the ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: